170 related articles for article (PubMed ID: 12598336)
41. Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma.
Bovo G; Brivio F; Brenna A; Fumagalli L; Perego P; Brivio O; Uggeri F; Lavorato F; Bratina G
Pathologica; 1995 Apr; 87(2):135-8. PubMed ID: 8532404
[TBL] [Abstract][Full Text] [Related]
42. [Current status of internal therapy of colorectal neoplasm and its evaluation].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):705-7. PubMed ID: 16483475
[No Abstract] [Full Text] [Related]
43. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Köhne CH; Wilke H; Hecker H; Schöffski P; Käufer C; Rauschecker H; Andreesen R; Ohl U; Lange HJ; Klaassen U
Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
[TBL] [Abstract][Full Text] [Related]
44. [Modifiers of the biological response in the adjuvant treatment of digestive cancers].
Seitz JF
Gastroenterol Clin Biol; 1994; 18(8-9):726-32. PubMed ID: 7875441
[No Abstract] [Full Text] [Related]
45. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
[TBL] [Abstract][Full Text] [Related]
46. Immunological and biochemical modulation in the treatment of advanced colorectal cancer: update and future directions.
Hilgenfeld RU; Kreuser ED
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():217-40. PubMed ID: 8815007
[No Abstract] [Full Text] [Related]
47. Adjuvant therapy for colorectal carcinoma.
Metzger U
World J Surg; 1991; 15(5):576-82. PubMed ID: 1949854
[TBL] [Abstract][Full Text] [Related]
48. Oral adjuvant therapy for colorectal cancer: recent developments and future targets.
Shahiwala A; Qawoogha SS; Tambuwala MM
Ther Deliv; 2019 Oct; 10(10):659-669. PubMed ID: 31702443
[TBL] [Abstract][Full Text] [Related]
49. Is therapy with cytostatics obsolete in hairy-cell leukemia?
Franchi F; Seminara P; Codacci-Pisanelli G; Bianco P
Int J Clin Lab Res; 1992; 22(2):122-3. PubMed ID: 1504306
[No Abstract] [Full Text] [Related]
50. Prolymphocytic leukemia: a very satisfactory response to treatment with recombinant interferon alpha.
Vivaldi P; Garuti R; Rubertelli M; Mazzon C
Haematologica; 1992; 77(2):169-70. PubMed ID: 1398302
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis.
Serrano PE; Carter DN; Li C; Valencia M; Ruo L; Parpia S; Simunovic M; Levine O
J Surg Res; 2019 Jul; 239():14-21. PubMed ID: 30782542
[TBL] [Abstract][Full Text] [Related]
52. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
53. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
54. Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Weihrauch MR; Ansén S; Jurkiewicz E; Geisen C; Xia Z; Anderson KS; Gracien E; Schmidt M; Wittig B; Diehl V; Wolf J; Bohlen H; Nadler LM
Clin Cancer Res; 2005 Aug; 11(16):5993-6001. PubMed ID: 16115944
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant interferon treatment in human osteosarcoma.
Strander H; Bauer HC; Brosjö O; Kreicbergs A; Lindholm J; Nilsonne U; Silfverswärd C; Szamosi A
Cancer Treat Res; 1993; 62():29-32. PubMed ID: 8096744
[TBL] [Abstract][Full Text] [Related]
56. [Adjuvant and palliative regional therapy of liver metastases in colorectal tumors].
Lorenz M; Rossion I
Dtsch Med Wochenschr; 1995 May; 120(19):690-7. PubMed ID: 7539355
[No Abstract] [Full Text] [Related]
57. Malignant melanoma: non-metastatic.
Crosby D; Crosby T; Mason M
Clin Evid; 2002 Jun; (7):1519-29. PubMed ID: 12230768
[No Abstract] [Full Text] [Related]
58. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Ridolfi L; Fiorentini G; Guida M; Michiara M; Freschi A; Aitini E; Ballardini M; Bichisao E; Ridolfi R;
Melanoma Res; 2009 Apr; 19(2):100-5. PubMed ID: 19262411
[TBL] [Abstract][Full Text] [Related]
59. Targeted therapy in colorectal carcinoma: more than a theory.
Pickering L; Rudman S; Ross PJ; Leslie MD
Colorectal Dis; 2008 Mar; 10(3):209-18; discussion 218-221. PubMed ID: 18257846
[TBL] [Abstract][Full Text] [Related]
60. Consensus conference on adjuvant and palliative treatment of colorectal cancer. Netherlands Society for Medical Oncology.
Rodenburg CJ; Willemse PH; Mulder NH
Neth J Med; 2000 Aug; 57(2):50-7. PubMed ID: 10924941
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
